Target intelligence / Profile preview

Limbal epithelial stem cells and conjunctival goblet cells (LESC/CGC)

Target
LESC/CGC
Molecular classification
Other (Cellular Population)
01

Overview

Limbal epithelial stem cells (LESCs) and conjunctival goblet cells (CGCs) are essential cellular components that maintain the physiological integrity and transparency of the ocular surface. LESCs are located in the basal limbal epithelium and are responsible for the continuous regeneration of the corneal epithelium, acting as a barrier against the encroachment of the conjunctiva (Pellegrini et al., 2014, PubMed). Conjunctival goblet cells are specialized secretory cells that produce MUC5AC, a gel-forming mucin that stabilizes the tear film and protects the ocular surface from desiccation and pathogens (Gipson, 2016, PubMed). Dysfunction or depletion of these cells leads to severe ocular surface diseases, including limbal stem cell deficiency (LSCD) and dry eye disease, which can result in corneal scarring and vision loss (Dua et al., 2000, PubMed). While these are cell populations rather than single molecular targets, they are the focus of therapeutic interventions ranging from anti-inflammatory drugs like cyclosporine, which preserves goblet cell density, to regenerative medicine approaches such as autologous limbal epithelial cell transplantation (Pflugfelder, 2004, PubMed).

Other names
Limbal stem cellsCorneal epithelial stem cellsConjunctival mucous cellsLESCsCGCs
02

Mechanism of action

Drugs targeting these cell populations primarily function through anti-inflammatory pathways to preserve cell density, neurotrophic support to enhance stem cell survival, or cholinergic stimulation to induce mucin secretion.

03

Biological functions

Cell proliferationCell differentiationMucin secretionBarrier functionOcular surface homeostasis
04

Disease associations

Limbal stem cell deficiencyDry eye diseaseSjogren's syndromeOcular surface diseaseInflammation
05

Safety considerations

Graft rejectionTumorigenicityInfectionLoss of cell phenotypeOcular irritation
06

Interacting drugs

Cyclosporine

4 more in the full profile.

07

Biomarkers

p63 (specifically DeltaNp63alpha)ABCB5MUC5ACCytokeratin 7Cytokeratin 19

Beyond the preview

Go deeper on Limbal epithelial stem cells and conjunctival goblet cells (LESC/CGC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Limbal epithelial stem cells and conjunctival goblet cells (LESC/CGC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call